Business Context and Reporting Period
Company: IRADIMED CORP (IRMD)
Filing Type: Form 8-K (Current Report)
Report Date: February 4, 2022
Reporting Period: Fourth quarter ended December 31, 2021
This filing serves as a notification that the company issued a press release announcing its financial results for the fourth quarter of 2021. The detailed financial data is contained in the press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being available in the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the issuance of results for the fourth quarter ended December 31, 2021.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release containing the results but does not include the text of the commentary, guidance, or outlook within this document.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text. The document includes standard legal disclaimers stating that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 4, 2022) for actual revenue, net income, and EPS figures for Q4 2021.
- Verify year-over-year growth rates and margin trends in the full press release.
- Check for any forward-looking guidance or updated fiscal year 2022 projections in the press release.
- Confirm the company's liquidity position and debt levels as reported in the full financial statement release.